

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axonemal dynein complex assembly (GO:0070286) | 8.45930776 |
| 2 | cilium or flagellum-dependent cell motility (GO:0001539) | 6.56884544 |
| 3 | cilium movement (GO:0003341) | 6.15726897 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.84395188 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.83155659 |
| 6 | motile cilium assembly (GO:0044458) | 5.74293898 |
| 7 | synaptic vesicle maturation (GO:0016188) | 5.58089412 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.20424122 |
| 9 | epithelial cilium movement (GO:0003351) | 5.15409058 |
| 10 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.96882307 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.96309567 |
| 12 | locomotory exploration behavior (GO:0035641) | 4.94774911 |
| 13 | glutamate secretion (GO:0014047) | 4.88500788 |
| 14 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.51655396 |
| 15 | desmosome organization (GO:0002934) | 4.51364930 |
| 16 | vocalization behavior (GO:0071625) | 4.48781005 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.40051773 |
| 18 | neuronal action potential propagation (GO:0019227) | 4.37979143 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.29818885 |
| 20 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.22664037 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.18435546 |
| 22 | protein localization to synapse (GO:0035418) | 4.17091449 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.11986441 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 4.10458209 |
| 25 | primary alcohol catabolic process (GO:0034310) | 4.06897117 |
| 26 | axoneme assembly (GO:0035082) | 4.01182566 |
| 27 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.92646158 |
| 28 | exploration behavior (GO:0035640) | 3.90784257 |
| 29 | layer formation in cerebral cortex (GO:0021819) | 3.87000959 |
| 30 | activation of protein kinase A activity (GO:0034199) | 3.84872846 |
| 31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.83900222 |
| 32 | left/right pattern formation (GO:0060972) | 3.82587583 |
| 33 | detection of calcium ion (GO:0005513) | 3.82126226 |
| 34 | proline transport (GO:0015824) | 3.78517568 |
| 35 | hemidesmosome assembly (GO:0031581) | 3.73971553 |
| 36 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.73052460 |
| 37 | vitamin transmembrane transport (GO:0035461) | 3.66108775 |
| 38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.64000910 |
| 39 | synaptic transmission, glutamatergic (GO:0035249) | 3.56389330 |
| 40 | establishment of apical/basal cell polarity (GO:0035089) | 3.55906840 |
| 41 | lung epithelium development (GO:0060428) | 3.48062488 |
| 42 | innervation (GO:0060384) | 3.45898935 |
| 43 | glomerular epithelial cell development (GO:0072310) | 3.44541806 |
| 44 | neuron-neuron synaptic transmission (GO:0007270) | 3.43802763 |
| 45 | regulation of vesicle fusion (GO:0031338) | 3.43493867 |
| 46 | regulation of synapse structural plasticity (GO:0051823) | 3.40777169 |
| 47 | cellular potassium ion homeostasis (GO:0030007) | 3.39697255 |
| 48 | neurotransmitter transport (GO:0006836) | 3.38738008 |
| 49 | ethanol metabolic process (GO:0006067) | 3.38716663 |
| 50 | glutamate receptor signaling pathway (GO:0007215) | 3.38670637 |
| 51 | vesicle transport along microtubule (GO:0047496) | 3.36636578 |
| 52 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.30974135 |
| 53 | gamma-aminobutyric acid transport (GO:0015812) | 3.29680592 |
| 54 | dendritic spine morphogenesis (GO:0060997) | 3.29473199 |
| 55 | positive regulation of synapse maturation (GO:0090129) | 3.29102330 |
| 56 | positive regulation of membrane potential (GO:0045838) | 3.28218038 |
| 57 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.28140801 |
| 58 | neuromuscular process controlling posture (GO:0050884) | 3.28105924 |
| 59 | long-term memory (GO:0007616) | 3.25800743 |
| 60 | neuron recognition (GO:0008038) | 3.25051532 |
| 61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.24842052 |
| 62 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.23942890 |
| 63 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.23897763 |
| 64 | regulation of neurotransmitter secretion (GO:0046928) | 3.21696048 |
| 65 | regulation of synaptic plasticity (GO:0048167) | 3.21043758 |
| 66 | insulin secretion (GO:0030073) | 3.20468333 |
| 67 | synaptic vesicle endocytosis (GO:0048488) | 3.20405790 |
| 68 | chemosensory behavior (GO:0007635) | 3.16865125 |
| 69 | diterpenoid biosynthetic process (GO:0016102) | 3.15694383 |
| 70 | cerebellar Purkinje cell layer development (GO:0021680) | 3.14776698 |
| 71 | regulation of postsynaptic membrane potential (GO:0060078) | 3.11660152 |
| 72 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.09890236 |
| 73 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.09473630 |
| 74 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.07950227 |
| 75 | long-term synaptic potentiation (GO:0060291) | 3.07859174 |
| 76 | regulation of neurotransmitter levels (GO:0001505) | 3.06941304 |
| 77 | mating behavior (GO:0007617) | 3.06050453 |
| 78 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.03008554 |
| 79 | positive regulation of vesicle fusion (GO:0031340) | 3.01836455 |
| 80 | transmission of nerve impulse (GO:0019226) | 3.01768967 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01523765 |
| 82 | positive regulation of exocytosis (GO:0045921) | 3.01344861 |
| 83 | organelle transport along microtubule (GO:0072384) | 3.01226672 |
| 84 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.00800014 |
| 85 | membrane depolarization during action potential (GO:0086010) | 3.00400735 |
| 86 | cell communication by electrical coupling (GO:0010644) | 2.99499965 |
| 87 | axonal fasciculation (GO:0007413) | 2.98483992 |
| 88 | microtubule bundle formation (GO:0001578) | 2.97385971 |
| 89 | neuromuscular process controlling balance (GO:0050885) | 2.97087680 |
| 90 | establishment of planar polarity (GO:0001736) | 2.96384641 |
| 91 | establishment of tissue polarity (GO:0007164) | 2.96384641 |
| 92 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.95188550 |
| 93 | regulation of neurotransmitter transport (GO:0051588) | 2.94947947 |
| 94 | regulation of cilium movement (GO:0003352) | 2.94280991 |
| 95 | retinol metabolic process (GO:0042572) | 2.94033803 |
| 96 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.93939852 |
| 97 | establishment of monopolar cell polarity (GO:0061162) | 2.93939852 |
| 98 | sodium ion export (GO:0071436) | 2.92731838 |
| 99 | Golgi transport vesicle coating (GO:0048200) | 2.92167688 |
| 100 | COPI coating of Golgi vesicle (GO:0048205) | 2.92167688 |
| 101 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.89704877 |
| 102 | glycine transport (GO:0015816) | 2.89644418 |
| 103 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.89299276 |
| 104 | signal release (GO:0023061) | 2.87109718 |
| 105 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.86789391 |
| 106 | regulation of exocytosis (GO:0017157) | 2.85377403 |
| 107 | apical protein localization (GO:0045176) | 2.85306022 |
| 108 | suckling behavior (GO:0001967) | 2.84126516 |
| 109 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.83674350 |
| 110 | synaptic transmission (GO:0007268) | 2.80722288 |
| 111 | calcium ion-dependent exocytosis (GO:0017156) | 2.79935978 |
| 112 | membrane depolarization (GO:0051899) | 2.78649610 |
| 113 | dendritic spine organization (GO:0097061) | 2.78624427 |
| 114 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.78432766 |
| 115 | synaptic vesicle transport (GO:0048489) | 2.77757970 |
| 116 | establishment of synaptic vesicle localization (GO:0097480) | 2.77757970 |
| 117 | synapse assembly (GO:0007416) | 2.76315350 |
| 118 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.76181274 |
| 119 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.75116617 |
| 120 | dendrite morphogenesis (GO:0048813) | 2.74540283 |
| 121 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.74356042 |
| 122 | fear response (GO:0042596) | 2.73497503 |
| 123 | multicellular organismal water homeostasis (GO:0050891) | 2.73043052 |
| 124 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.73036953 |
| 125 | cellular response to glucagon stimulus (GO:0071377) | 2.71956852 |
| 126 | ethanol oxidation (GO:0006069) | 2.71151310 |
| 127 | establishment of vesicle localization (GO:0051650) | 2.71077001 |
| 128 | regulation of synaptic transmission (GO:0050804) | 2.70499366 |
| 129 | left/right axis specification (GO:0070986) | 2.69617590 |
| 130 | intraspecies interaction between organisms (GO:0051703) | 2.68946117 |
| 131 | ventricular system development (GO:0021591) | 2.68702052 |
| 132 | negative regulation of humoral immune response (GO:0002921) | 2.65026137 |
| 133 | intraciliary transport (GO:0042073) | 2.61866125 |
| 134 | cell adhesion mediated by integrin (GO:0033627) | 2.57204527 |
| 135 | iron ion import (GO:0097286) | 2.56163633 |
| 136 | cilium organization (GO:0044782) | 2.53266831 |
| 137 | cilium assembly (GO:0042384) | 2.52149966 |
| 138 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.52136208 |
| 139 | protein retention in ER lumen (GO:0006621) | 2.51347364 |
| 140 | skin morphogenesis (GO:0043589) | 2.50973448 |
| 141 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.49368347 |
| 142 | macroautophagy (GO:0016236) | 2.48875869 |
| 143 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.48570068 |
| 144 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.47809781 |
| 145 | cellular zinc ion homeostasis (GO:0006882) | 2.45672010 |
| 146 | asymmetric protein localization (GO:0008105) | 2.43315360 |
| 147 | protein localization to cilium (GO:0061512) | 2.40461184 |
| 148 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.37523536 |
| 149 | microtubule-based movement (GO:0007018) | 2.37321049 |
| 150 | COPII vesicle coating (GO:0048208) | 2.36291788 |
| 151 | primary alcohol metabolic process (GO:0034308) | 2.35171508 |
| 152 | water homeostasis (GO:0030104) | 2.33440166 |
| 153 | one-carbon compound transport (GO:0019755) | 2.29612765 |
| 154 | regulation of metalloenzyme activity (GO:0048552) | 2.28089032 |
| 155 | potassium ion homeostasis (GO:0055075) | 2.25751949 |
| 156 | intestinal epithelial cell development (GO:0060576) | 2.23505288 |
| 157 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.22933230 |
| 158 | regulation of water loss via skin (GO:0033561) | 2.22089100 |
| 159 | terpenoid biosynthetic process (GO:0016114) | 2.20900857 |
| 160 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.20506876 |
| 161 | negative regulation of hormone metabolic process (GO:0032351) | 2.19253066 |
| 162 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.19223039 |
| 163 | regulation of extracellular matrix disassembly (GO:0010715) | 2.15802718 |
| 164 | regulation of autophagic vacuole assembly (GO:2000785) | 2.15674939 |
| 165 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.15152336 |
| 166 | sphingomyelin metabolic process (GO:0006684) | 2.14378924 |
| 167 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.13730273 |
| 168 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.13730273 |
| 169 | myelin maintenance (GO:0043217) | 2.11881995 |
| 170 | protein carboxylation (GO:0018214) | 2.09859865 |
| 171 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.09859865 |
| 172 | epithelial cell-cell adhesion (GO:0090136) | 2.09535167 |
| 173 | positive regulation of actin filament depolymerization (GO:0030836) | 2.09397283 |
| 174 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.08530953 |
| 175 | negative regulation of complement activation (GO:0045916) | 2.08289578 |
| 176 | O-glycan processing (GO:0016266) | 2.07703067 |
| 177 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.07245577 |
| 178 | positive regulation of macroautophagy (GO:0016239) | 2.04533994 |
| 179 | protein localization to endosome (GO:0036010) | 2.04265840 |
| 180 | retinoic acid metabolic process (GO:0042573) | 2.03544128 |
| 181 | hypotonic response (GO:0006971) | 2.03060521 |
| 182 | zinc ion transmembrane transport (GO:0071577) | 2.02986636 |
| 183 | glandular epithelial cell differentiation (GO:0002067) | 2.02387851 |
| 184 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.02185788 |
| 185 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.01598639 |
| 186 | epithelial cell fate commitment (GO:0072148) | 2.01250467 |
| 187 | protein maturation by protein folding (GO:0022417) | 2.00944813 |
| 188 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.00873830 |
| 189 | positive regulation of protein autophosphorylation (GO:0031954) | 2.00818425 |
| 190 | negative regulation of chondrocyte differentiation (GO:0032331) | 1.99612000 |
| 191 | polarized epithelial cell differentiation (GO:0030859) | 1.99388573 |
| 192 | sodium ion homeostasis (GO:0055078) | 1.98393461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.99352370 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.39252429 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.67697955 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.64479999 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.34073203 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 3.11445746 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09890618 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.92359524 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.88873163 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.69033760 |
| 11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.67165204 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.62378260 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.59123449 |
| 14 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.56839544 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.55209634 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.55209634 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.49461011 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49443738 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48564249 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.43626079 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.35325911 |
| 22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.32759326 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.31918874 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.30269018 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.27368592 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.20711220 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18677208 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.12106781 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.11216250 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10906863 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.06628233 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.04973152 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.88788109 |
| 34 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.87391241 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.83405269 |
| 36 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.82920448 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80503362 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.73860649 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.73194631 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.72807573 |
| 41 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.70702188 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68253569 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67503640 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.61914436 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.61024315 |
| 46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.60595072 |
| 47 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.58916855 |
| 48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.57589184 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57545529 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57031162 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.56373973 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55774933 |
| 53 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.53128833 |
| 54 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52375839 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.51927976 |
| 56 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.50956430 |
| 57 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.49502672 |
| 58 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.48239266 |
| 59 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.48056137 |
| 60 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.45154377 |
| 61 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.43854672 |
| 62 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43652127 |
| 63 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.42342911 |
| 64 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.39327644 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39217742 |
| 66 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38512866 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36826817 |
| 68 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36538549 |
| 69 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36119399 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35607387 |
| 71 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.35567946 |
| 72 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.35567946 |
| 73 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.34408976 |
| 74 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.31778658 |
| 75 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.31598166 |
| 76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.26281306 |
| 77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26155559 |
| 78 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.25681313 |
| 79 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24977054 |
| 80 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24652867 |
| 81 | AR_19668381_ChIP-Seq_PC3_Human | 1.24606359 |
| 82 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24290897 |
| 83 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23858594 |
| 84 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.23795373 |
| 85 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.23009304 |
| 86 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22858647 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.21929442 |
| 88 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.20920387 |
| 89 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20069766 |
| 90 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.19485565 |
| 91 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.19448063 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19253056 |
| 93 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18519954 |
| 94 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17971734 |
| 95 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.17939972 |
| 96 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17267594 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16705127 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16635720 |
| 99 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.15045496 |
| 100 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.14179510 |
| 101 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13775813 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13286996 |
| 103 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.13193721 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13014654 |
| 105 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12593627 |
| 106 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11391283 |
| 107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11364585 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11364585 |
| 109 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11257300 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11069572 |
| 111 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.09477902 |
| 112 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09330036 |
| 113 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09225634 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.09076332 |
| 115 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08930455 |
| 116 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08826522 |
| 117 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07577179 |
| 118 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07544683 |
| 119 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07233806 |
| 120 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06807854 |
| 121 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.06573350 |
| 122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06452508 |
| 123 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05613502 |
| 124 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.05333737 |
| 125 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04980164 |
| 126 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04868353 |
| 127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04562126 |
| 128 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03803667 |
| 129 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03098147 |
| 130 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02251686 |
| 131 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01551208 |
| 132 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00082834 |
| 133 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98713591 |
| 134 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98033270 |
| 135 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97616721 |
| 136 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97461388 |
| 137 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.97300402 |
| 138 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97151811 |
| 139 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95006930 |
| 140 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94910550 |
| 141 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94901536 |
| 142 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94849485 |
| 143 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93284514 |
| 144 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92946592 |
| 145 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92911890 |
| 146 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92716248 |
| 147 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92474343 |
| 148 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92404718 |
| 149 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91140750 |
| 150 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.90274688 |
| 151 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87005400 |
| 152 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86204537 |
| 153 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.85905047 |
| 154 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85147884 |
| 155 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84590719 |
| 156 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84422494 |
| 157 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83943608 |
| 158 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.83859899 |
| 159 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83796718 |
| 160 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83210334 |
| 161 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.81776830 |
| 162 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.81663185 |
| 163 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80306751 |
| 164 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.79411084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.53185917 |
| 2 | MP0003880_abnormal_central_pattern | 3.84002671 |
| 3 | MP0004270_analgesia | 3.72920459 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.70970402 |
| 5 | MP0000566_synostosis | 3.02908656 |
| 6 | MP0002063_abnormal_learning/memory/cond | 2.93669588 |
| 7 | MP0009745_abnormal_behavioral_response | 2.90418699 |
| 8 | MP0002909_abnormal_adrenal_gland | 2.89129848 |
| 9 | MP0009780_abnormal_chondrocyte_physiolo | 2.81126856 |
| 10 | MP0002064_seizures | 2.71160787 |
| 11 | MP0005623_abnormal_meninges_morphology | 2.69805382 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.69156308 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.65585876 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.49297871 |
| 15 | MP0009046_muscle_twitch | 2.48289730 |
| 16 | MP0003283_abnormal_digestive_organ | 2.42985247 |
| 17 | MP0002822_catalepsy | 2.39460119 |
| 18 | MP0002272_abnormal_nervous_system | 2.35907429 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.35193274 |
| 20 | MP0010678_abnormal_skin_adnexa | 2.32530145 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.28667712 |
| 22 | MP0000579_abnormal_nail_morphology | 2.26957053 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 2.22389008 |
| 24 | MP0000013_abnormal_adipose_tissue | 2.12400022 |
| 25 | MP0005423_abnormal_somatic_nervous | 2.12048889 |
| 26 | MP0001970_abnormal_pain_threshold | 2.06913396 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.99208636 |
| 28 | MP0004858_abnormal_nervous_system | 1.98819830 |
| 29 | MP0002736_abnormal_nociception_after | 1.94851185 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 1.94785793 |
| 31 | MP0001486_abnormal_startle_reflex | 1.93861454 |
| 32 | MP0010386_abnormal_urinary_bladder | 1.92432875 |
| 33 | MP0004272_abnormal_basement_membrane | 1.89638448 |
| 34 | MP0001440_abnormal_grooming_behavior | 1.88545242 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.87269559 |
| 36 | MP0003941_abnormal_skin_development | 1.85343358 |
| 37 | MP0002184_abnormal_innervation | 1.85227638 |
| 38 | MP0003566_abnormal_cell_adhesion | 1.82076969 |
| 39 | MP0001984_abnormal_olfaction | 1.81742612 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.80850114 |
| 41 | MP0003329_amyloid_beta_deposits | 1.79827995 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.79039446 |
| 43 | MP0000383_abnormal_hair_follicle | 1.77925525 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.77846151 |
| 45 | MP0003122_maternal_imprinting | 1.75525319 |
| 46 | MP0002060_abnormal_skin_morphology | 1.68741366 |
| 47 | MP0004811_abnormal_neuron_physiology | 1.67974345 |
| 48 | MP0002557_abnormal_social/conspecific_i | 1.64458904 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.64113221 |
| 50 | MP0000955_abnormal_spinal_cord | 1.62237327 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.60632666 |
| 52 | MP0005257_abnormal_intraocular_pressure | 1.59721883 |
| 53 | MP0008569_lethality_at_weaning | 1.57267057 |
| 54 | MP0002796_impaired_skin_barrier | 1.56582204 |
| 55 | MP0005409_darkened_coat_color | 1.55853423 |
| 56 | MP0003879_abnormal_hair_cell | 1.54399928 |
| 57 | MP0004043_abnormal_pH_regulation | 1.54111504 |
| 58 | MP0005275_abnormal_skin_tensile | 1.53737976 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 1.52376883 |
| 60 | MP0005386_behavior/neurological_phenoty | 1.50985241 |
| 61 | MP0004924_abnormal_behavior | 1.50985241 |
| 62 | MP0000778_abnormal_nervous_system | 1.47636811 |
| 63 | MP0004019_abnormal_vitamin_homeostasis | 1.42260733 |
| 64 | MP0005248_abnormal_Harderian_gland | 1.41776520 |
| 65 | MP0000762_abnormal_tongue_morphology | 1.40758269 |
| 66 | MP0003787_abnormal_imprinting | 1.36833175 |
| 67 | MP0002693_abnormal_pancreas_physiology | 1.35233771 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 1.33842080 |
| 69 | MP0002638_abnormal_pupillary_reflex | 1.33386785 |
| 70 | MP0002896_abnormal_bone_mineralization | 1.32396627 |
| 71 | MP0002882_abnormal_neuron_morphology | 1.32019822 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.29254229 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.29072528 |
| 74 | MP0005379_endocrine/exocrine_gland_phen | 1.25352943 |
| 75 | MP0008961_abnormal_basal_metabolism | 1.24798639 |
| 76 | MP0001944_abnormal_pancreas_morphology | 1.24587265 |
| 77 | MP0003633_abnormal_nervous_system | 1.23270399 |
| 78 | MP0006072_abnormal_retinal_apoptosis | 1.16178314 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 1.15067835 |
| 80 | MP0004885_abnormal_endolymph | 1.13561745 |
| 81 | MP0001529_abnormal_vocalization | 1.12799556 |
| 82 | MP0003183_abnormal_peptide_metabolism | 1.11458120 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 1.11112726 |
| 84 | MP0002098_abnormal_vibrissa_morphology | 1.10770259 |
| 85 | MP0010771_integument_phenotype | 1.04305297 |
| 86 | MP0000467_abnormal_esophagus_morphology | 1.02852783 |
| 87 | MP0002160_abnormal_reproductive_system | 1.02073914 |
| 88 | MP0000631_abnormal_neuroendocrine_gland | 1.00647111 |
| 89 | MP0004133_heterotaxia | 1.00468283 |
| 90 | MP0005501_abnormal_skin_physiology | 0.99619164 |
| 91 | MP0005535_abnormal_body_temperature | 0.99539559 |
| 92 | MP0002152_abnormal_brain_morphology | 0.99111784 |
| 93 | MP0005365_abnormal_bile_salt | 0.98709614 |
| 94 | MP0002168_other_aberrant_phenotype | 0.98580624 |
| 95 | MP0003950_abnormal_plasma_membrane | 0.98169579 |
| 96 | MP0002069_abnormal_eating/drinking_beha | 0.97295028 |
| 97 | MP0003631_nervous_system_phenotype | 0.96880478 |
| 98 | MP0002229_neurodegeneration | 0.95887716 |
| 99 | MP0001346_abnormal_lacrimal_gland | 0.95874865 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.94699441 |
| 101 | MP0000427_abnormal_hair_cycle | 0.94334487 |
| 102 | MP0001905_abnormal_dopamine_level | 0.93376545 |
| 103 | MP0002139_abnormal_hepatobiliary_system | 0.91805404 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.91583778 |
| 105 | MP0005083_abnormal_biliary_tract | 0.91289791 |
| 106 | MP0005220_abnormal_exocrine_pancreas | 0.90817332 |
| 107 | MP0003172_abnormal_lysosome_physiology | 0.90813130 |
| 108 | MP0001849_ear_inflammation | 0.90624734 |
| 109 | MP0010030_abnormal_orbit_morphology | 0.90498977 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.90120319 |
| 111 | MP0001188_hyperpigmentation | 0.88465780 |
| 112 | MP0004142_abnormal_muscle_tone | 0.88240978 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.88073301 |
| 114 | MP0002282_abnormal_trachea_morphology | 0.87953751 |
| 115 | MP0000537_abnormal_urethra_morphology | 0.87808513 |
| 116 | MP0002078_abnormal_glucose_homeostasis | 0.87787123 |
| 117 | MP0005187_abnormal_penis_morphology | 0.87455404 |
| 118 | MP0000462_abnormal_digestive_system | 0.86807983 |
| 119 | MP0005023_abnormal_wound_healing | 0.86610485 |
| 120 | MP0005503_abnormal_tendon_morphology | 0.86121167 |
| 121 | MP0001756_abnormal_urination | 0.85618220 |
| 122 | MP0004264_abnormal_extraembryonic_tissu | 0.85264828 |
| 123 | MP0002234_abnormal_pharynx_morphology | 0.85235685 |
| 124 | MP0003634_abnormal_glial_cell | 0.84699639 |
| 125 | MP0010234_abnormal_vibrissa_follicle | 0.84684918 |
| 126 | MP0005499_abnormal_olfactory_system | 0.84290171 |
| 127 | MP0005394_taste/olfaction_phenotype | 0.84290171 |
| 128 | MP0001299_abnormal_eye_distance/ | 0.84069606 |
| 129 | MP0003868_abnormal_feces_composition | 0.80278423 |
| 130 | MP0000678_abnormal_parathyroid_gland | 0.78810419 |
| 131 | MP0003942_abnormal_urinary_system | 0.78774056 |
| 132 | MP0005408_hypopigmentation | 0.78606467 |
| 133 | MP0002876_abnormal_thyroid_physiology | 0.77776683 |
| 134 | MP0005551_abnormal_eye_electrophysiolog | 0.75924622 |
| 135 | MP0002751_abnormal_autonomic_nervous | 0.75540836 |
| 136 | MP0004782_abnormal_surfactant_physiolog | 0.75363360 |
| 137 | MP0000639_abnormal_adrenal_gland | 0.74701164 |
| 138 | MP0002233_abnormal_nose_morphology | 0.74523978 |
| 139 | MP0004085_abnormal_heartbeat | 0.74469344 |
| 140 | MP0004233_abnormal_muscle_weight | 0.74006166 |
| 141 | MP0000377_abnormal_hair_follicle | 0.72850398 |
| 142 | MP0000647_abnormal_sebaceous_gland | 0.71869709 |
| 143 | MP0005636_abnormal_mineral_homeostasis | 0.71653751 |
| 144 | MP0001270_distended_abdomen | 0.69593828 |
| 145 | MP0003953_abnormal_hormone_level | 0.69519171 |
| 146 | MP0005165_increased_susceptibility_to | 0.69129863 |
| 147 | MP0002090_abnormal_vision | 0.69079698 |
| 148 | MP0003937_abnormal_limbs/digits/tail_de | 0.68573731 |
| 149 | MP0003123_paternal_imprinting | 0.68345177 |
| 150 | MP0002752_abnormal_somatic_nervous | 0.68086693 |
| 151 | MP0001963_abnormal_hearing_physiology | 0.67779326 |
| 152 | MP0001765_abnormal_ion_homeostasis | 0.67716236 |
| 153 | MP0000534_abnormal_ureter_morphology | 0.67500384 |
| 154 | MP0001664_abnormal_digestion | 0.67327950 |
| 155 | MP0002653_abnormal_ependyma_morphology | 0.66689363 |
| 156 | MP0000604_amyloidosis | 0.66547239 |
| 157 | MP0002249_abnormal_larynx_morphology | 0.65716161 |
| 158 | MP0003632_abnormal_nervous_system | 0.65367978 |
| 159 | MP0008872_abnormal_physiological_respon | 0.63619504 |
| 160 | MP0008789_abnormal_olfactory_epithelium | 0.63408129 |
| 161 | MP0001958_emphysema | 0.62282130 |
| 162 | MP0003195_calcinosis | 0.61863328 |
| 163 | MP0003119_abnormal_digestive_system | 0.61457130 |
| 164 | MP0000627_abnormal_mammary_gland | 0.58780562 |
| 165 | MP0003755_abnormal_palate_morphology | 0.57696125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 8.12731746 |
| 2 | Abnormal respiratory motile cilium morphology (HP:0005938) | 7.00496537 |
| 3 | Abnormal respiratory epithelium morphology (HP:0012253) | 7.00496537 |
| 4 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.99244182 |
| 5 | Rhinitis (HP:0012384) | 6.92612921 |
| 6 | Abnormal ciliary motility (HP:0012262) | 6.77029068 |
| 7 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.61543247 |
| 8 | Absent/shortened dynein arms (HP:0200106) | 6.61543247 |
| 9 | Focal motor seizures (HP:0011153) | 6.15672472 |
| 10 | Visual hallucinations (HP:0002367) | 5.45113167 |
| 11 | Myokymia (HP:0002411) | 5.35611215 |
| 12 | Chronic bronchitis (HP:0004469) | 5.24706578 |
| 13 | Focal seizures (HP:0007359) | 4.75883118 |
| 14 | Bronchiectasis (HP:0002110) | 4.50863002 |
| 15 | Atonic seizures (HP:0010819) | 4.50673449 |
| 16 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.23412590 |
| 17 | Epileptic encephalopathy (HP:0200134) | 4.06387388 |
| 18 | Absence seizures (HP:0002121) | 3.98274641 |
| 19 | Nasal polyposis (HP:0100582) | 3.86311543 |
| 20 | Febrile seizures (HP:0002373) | 3.60848611 |
| 21 | Dialeptic seizures (HP:0011146) | 3.55787437 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 3.54641340 |
| 23 | Generalized tonic-clonic seizures (HP:0002069) | 3.48598200 |
| 24 | Action tremor (HP:0002345) | 3.42977762 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 3.34947304 |
| 26 | Papilledema (HP:0001085) | 3.28407120 |
| 27 | Agitation (HP:0000713) | 3.21606374 |
| 28 | Depression (HP:0000716) | 3.18756891 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 3.15438801 |
| 30 | Pheochromocytoma (HP:0002666) | 3.10785349 |
| 31 | Epileptiform EEG discharges (HP:0011182) | 3.08063510 |
| 32 | EEG with generalized epileptiform discharges (HP:0011198) | 3.04030433 |
| 33 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.03740576 |
| 34 | Ankle clonus (HP:0011448) | 3.01904046 |
| 35 | Truncal ataxia (HP:0002078) | 2.92650194 |
| 36 | Hypsarrhythmia (HP:0002521) | 2.91190480 |
| 37 | Infertility (HP:0000789) | 2.89984897 |
| 38 | Anxiety (HP:0000739) | 2.89617940 |
| 39 | Poor eye contact (HP:0000817) | 2.83907775 |
| 40 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.83625460 |
| 41 | Amblyopia (HP:0000646) | 2.81596134 |
| 42 | Vascular calcification (HP:0004934) | 2.80066005 |
| 43 | Cardiovascular calcification (HP:0011915) | 2.73413100 |
| 44 | Male infertility (HP:0003251) | 2.70919992 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.69212201 |
| 46 | Neuroendocrine neoplasm (HP:0100634) | 2.68801043 |
| 47 | Occipital encephalocele (HP:0002085) | 2.64757372 |
| 48 | Abnormal social behavior (HP:0012433) | 2.61053009 |
| 49 | Impaired social interactions (HP:0000735) | 2.61053009 |
| 50 | Cerebral inclusion bodies (HP:0100314) | 2.60839479 |
| 51 | Hyperactive renin-angiotensin system (HP:0000841) | 2.60468493 |
| 52 | Atelectasis (HP:0100750) | 2.60065798 |
| 53 | Failure to thrive in infancy (HP:0001531) | 2.58675977 |
| 54 | Hypercortisolism (HP:0001578) | 2.57006767 |
| 55 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.56899266 |
| 56 | Short nail (HP:0001799) | 2.49652479 |
| 57 | Hyperventilation (HP:0002883) | 2.45622617 |
| 58 | Gaze-evoked nystagmus (HP:0000640) | 2.43363490 |
| 59 | Hemiparesis (HP:0001269) | 2.43354436 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.43240814 |
| 61 | Drooling (HP:0002307) | 2.42865066 |
| 62 | Excessive salivation (HP:0003781) | 2.42865066 |
| 63 | Dysdiadochokinesis (HP:0002075) | 2.42405942 |
| 64 | Limb dystonia (HP:0002451) | 2.41649766 |
| 65 | Abnormality of dentin (HP:0010299) | 2.41571595 |
| 66 | Premature rupture of membranes (HP:0001788) | 2.41012133 |
| 67 | Dysmetria (HP:0001310) | 2.38504371 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.35457431 |
| 69 | Broad-based gait (HP:0002136) | 2.34589588 |
| 70 | Abnormal eating behavior (HP:0100738) | 2.34295068 |
| 71 | Menstrual irregularities (HP:0000858) | 2.29988546 |
| 72 | Atrophic scars (HP:0001075) | 2.29106588 |
| 73 | Abnormality of the lower motor neuron (HP:0002366) | 2.28848947 |
| 74 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.28176212 |
| 75 | Hand muscle atrophy (HP:0009130) | 2.23179975 |
| 76 | Bradykinesia (HP:0002067) | 2.22634366 |
| 77 | Postural instability (HP:0002172) | 2.22340954 |
| 78 | Ventricular fibrillation (HP:0001663) | 2.21646384 |
| 79 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.20793429 |
| 80 | Resting tremor (HP:0002322) | 2.19126690 |
| 81 | Insidious onset (HP:0003587) | 2.18191198 |
| 82 | Termporal pattern (HP:0011008) | 2.18191198 |
| 83 | Megalencephaly (HP:0001355) | 2.17796495 |
| 84 | Symptomatic seizures (HP:0011145) | 2.16322498 |
| 85 | Spastic gait (HP:0002064) | 2.16026181 |
| 86 | Genetic anticipation (HP:0003743) | 2.11300969 |
| 87 | Arterial tortuosity (HP:0005116) | 2.08312664 |
| 88 | Dysautonomia (HP:0002459) | 2.06258022 |
| 89 | Hypoventilation (HP:0002791) | 2.05675299 |
| 90 | Postural tremor (HP:0002174) | 2.05338340 |
| 91 | Mitral stenosis (HP:0001718) | 2.02683581 |
| 92 | Abnormality of permanent molar morphology (HP:0011071) | 2.00986786 |
| 93 | Abnormality of the dental root (HP:0006486) | 2.00986786 |
| 94 | Taurodontia (HP:0000679) | 2.00986786 |
| 95 | Absent speech (HP:0001344) | 2.00886673 |
| 96 | Protrusio acetabuli (HP:0003179) | 2.00346679 |
| 97 | Restlessness (HP:0000711) | 1.99590694 |
| 98 | Vascular tortuosity (HP:0004948) | 1.98645728 |
| 99 | Retinal dysplasia (HP:0007973) | 1.98067794 |
| 100 | Hyperparathyroidism (HP:0000843) | 1.97930322 |
| 101 | Abnormality of molar (HP:0011077) | 1.97256751 |
| 102 | Abnormality of molar morphology (HP:0011070) | 1.97256751 |
| 103 | Upper limb amyotrophy (HP:0009129) | 1.96507461 |
| 104 | Distal upper limb amyotrophy (HP:0007149) | 1.96507461 |
| 105 | Diplopia (HP:0000651) | 1.95411139 |
| 106 | Abnormality of binocular vision (HP:0011514) | 1.95411139 |
| 107 | Torticollis (HP:0000473) | 1.94939253 |
| 108 | Type II lissencephaly (HP:0007260) | 1.94897263 |
| 109 | Decreased circulating renin level (HP:0003351) | 1.94261556 |
| 110 | Progressive inability to walk (HP:0002505) | 1.93183291 |
| 111 | Mutism (HP:0002300) | 1.93058774 |
| 112 | Urinary urgency (HP:0000012) | 1.92226193 |
| 113 | Scanning speech (HP:0002168) | 1.92005708 |
| 114 | Bronchitis (HP:0012387) | 1.89985507 |
| 115 | Recurrent otitis media (HP:0000403) | 1.89936421 |
| 116 | Bifid scrotum (HP:0000048) | 1.89759452 |
| 117 | Focal dystonia (HP:0004373) | 1.89076040 |
| 118 | Bell-shaped thorax (HP:0001591) | 1.87611737 |
| 119 | Gait ataxia (HP:0002066) | 1.86580086 |
| 120 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.85861564 |
| 121 | Clonus (HP:0002169) | 1.85670134 |
| 122 | Popliteal pterygium (HP:0009756) | 1.85260349 |
| 123 | Global brain atrophy (HP:0002283) | 1.85068775 |
| 124 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.84766199 |
| 125 | True hermaphroditism (HP:0010459) | 1.84443261 |
| 126 | Stereotypic behavior (HP:0000733) | 1.84199879 |
| 127 | Psychosis (HP:0000709) | 1.83581340 |
| 128 | Glucose intolerance (HP:0000833) | 1.82383910 |
| 129 | Pancreatic fibrosis (HP:0100732) | 1.81722098 |
| 130 | Retinal atrophy (HP:0001105) | 1.80544218 |
| 131 | Onycholysis (HP:0001806) | 1.80352162 |
| 132 | Abnormality of the dental pulp (HP:0006479) | 1.77916184 |
| 133 | Insomnia (HP:0100785) | 1.77748729 |
| 134 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.77696165 |
| 135 | Intention tremor (HP:0002080) | 1.77679581 |
| 136 | Cystic liver disease (HP:0006706) | 1.77525657 |
| 137 | Bundle branch block (HP:0011710) | 1.77341570 |
| 138 | Generalized myoclonic seizures (HP:0002123) | 1.77165667 |
| 139 | Hypoplasia of dental enamel (HP:0006297) | 1.76048209 |
| 140 | Amyotrophic lateral sclerosis (HP:0007354) | 1.76014618 |
| 141 | Delusions (HP:0000746) | 1.75942861 |
| 142 | Right ventricular cardiomyopathy (HP:0011663) | 1.74397598 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 1.73798924 |
| 144 | Rapidly progressive (HP:0003678) | 1.73635754 |
| 145 | Blue irides (HP:0000635) | 1.73258459 |
| 146 | Ketoacidosis (HP:0001993) | 1.73148730 |
| 147 | Lower limb muscle weakness (HP:0007340) | 1.73035859 |
| 148 | Nuclear cataract (HP:0100018) | 1.72411974 |
| 149 | Status epilepticus (HP:0002133) | 1.72214984 |
| 150 | Ankyloglossia (HP:0010296) | 1.71503313 |
| 151 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.70963549 |
| 152 | Buphthalmos (HP:0000557) | 1.69596486 |
| 153 | Spinal cord compression (HP:0002176) | 1.68677929 |
| 154 | Absent frontal sinuses (HP:0002688) | 1.65194922 |
| 155 | Hyperaldosteronism (HP:0000859) | 1.64515768 |
| 156 | Congenital glaucoma (HP:0001087) | 1.63822410 |
| 157 | Plantar hyperkeratosis (HP:0007556) | 1.62720179 |
| 158 | Pterygium (HP:0001059) | 1.59964886 |
| 159 | Chronic sinusitis (HP:0011109) | 1.58223932 |
| 160 | Long toe (HP:0010511) | 1.57921129 |
| 161 | Natal tooth (HP:0000695) | 1.57327563 |
| 162 | Renal salt wasting (HP:0000127) | 1.56647001 |
| 163 | Bronchomalacia (HP:0002780) | 1.56228862 |
| 164 | Advanced eruption of teeth (HP:0006288) | 1.56114636 |
| 165 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.52980211 |
| 166 | Aplasia of the phalanges of the hand (HP:0009802) | 1.52980211 |
| 167 | Aplasia involving bones of the extremities (HP:0009825) | 1.52980211 |
| 168 | Pili torti (HP:0003777) | 1.51968097 |
| 169 | Cervical subluxation (HP:0003308) | 1.51757861 |
| 170 | Postaxial foot polydactyly (HP:0001830) | 1.48345141 |
| 171 | Flat acetabular roof (HP:0003180) | 1.48300662 |
| 172 | Hyperphosphatemia (HP:0002905) | 1.48068381 |
| 173 | Furrowed tongue (HP:0000221) | 1.47320063 |
| 174 | Coronal craniosynostosis (HP:0004440) | 1.46089467 |
| 175 | Milia (HP:0001056) | 1.44275096 |
| 176 | Hypotension (HP:0002615) | 1.43703637 |
| 177 | Hypoplastic labia majora (HP:0000059) | 1.41138803 |
| 178 | Short thorax (HP:0010306) | 1.41017871 |
| 179 | Hyperglycemia (HP:0003074) | 1.40767552 |
| 180 | Hyperkalemia (HP:0002153) | 1.40644866 |
| 181 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.40572726 |
| 182 | Tubular atrophy (HP:0000092) | 1.39573907 |
| 183 | Hypoglycemic coma (HP:0001325) | 1.38795883 |
| 184 | Palmoplantar hyperkeratosis (HP:0000972) | 1.37324425 |
| 185 | Fragile skin (HP:0001030) | 1.36875795 |
| 186 | Abnormality of nail color (HP:0100643) | 1.36675497 |
| 187 | Stridor (HP:0010307) | 1.36477211 |
| 188 | Hydroureter (HP:0000072) | 1.34660905 |
| 189 | Fetal akinesia sequence (HP:0001989) | 1.34016675 |
| 190 | Abnormality of carpal bone ossification (HP:0006257) | 1.32280746 |
| 191 | Fragile nails (HP:0001808) | 1.32208475 |
| 192 | Septate vagina (HP:0001153) | 1.32155293 |
| 193 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.29459951 |
| 194 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.29314829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.73578730 |
| 2 | EPHA2 | 4.65816834 |
| 3 | MAP3K9 | 3.95672997 |
| 4 | EPHA4 | 3.33557415 |
| 5 | MST1R | 3.18455485 |
| 6 | MST4 | 2.96095976 |
| 7 | MAP3K4 | 2.83475880 |
| 8 | NTRK1 | 2.82167632 |
| 9 | PRKD3 | 2.79391003 |
| 10 | KSR2 | 2.57201415 |
| 11 | MINK1 | 2.51518836 |
| 12 | MARK1 | 2.51129554 |
| 13 | TESK1 | 2.47783536 |
| 14 | MAP3K2 | 2.32959086 |
| 15 | MET | 2.27203326 |
| 16 | DAPK2 | 2.19671839 |
| 17 | MAP2K7 | 2.16133417 |
| 18 | PAK6 | 2.07867114 |
| 19 | INSRR | 2.00282987 |
| 20 | LIMK1 | 1.90022565 |
| 21 | RIPK4 | 1.76508117 |
| 22 | CAMKK1 | 1.76086258 |
| 23 | LATS1 | 1.74490311 |
| 24 | PNCK | 1.73400545 |
| 25 | MAP2K4 | 1.72087759 |
| 26 | GRK5 | 1.71524366 |
| 27 | ARAF | 1.69882395 |
| 28 | CAMKK2 | 1.68764006 |
| 29 | EEF2K | 1.63622040 |
| 30 | MAPKAPK3 | 1.62497374 |
| 31 | UHMK1 | 1.58981005 |
| 32 | STK24 | 1.57381263 |
| 33 | NTRK2 | 1.56412824 |
| 34 | MAP3K12 | 1.56404427 |
| 35 | TRIB3 | 1.53468414 |
| 36 | TRPM7 | 1.52231585 |
| 37 | CDK5 | 1.48614100 |
| 38 | KSR1 | 1.46427134 |
| 39 | DAPK1 | 1.40694389 |
| 40 | SCYL2 | 1.35675891 |
| 41 | WNK3 | 1.35060224 |
| 42 | ICK | 1.33652289 |
| 43 | FGFR2 | 1.31445993 |
| 44 | PLK2 | 1.29265822 |
| 45 | STK38L | 1.29218532 |
| 46 | ERBB3 | 1.26147444 |
| 47 | MAP3K1 | 1.21428841 |
| 48 | PRKCG | 1.20805096 |
| 49 | PAK4 | 1.19200967 |
| 50 | RET | 1.16606212 |
| 51 | CASK | 1.14394115 |
| 52 | MAPK15 | 1.13727141 |
| 53 | PAK3 | 1.11857651 |
| 54 | EIF2AK1 | 1.11713868 |
| 55 | STK39 | 1.10934332 |
| 56 | PASK | 1.07257468 |
| 57 | STK38 | 1.05937654 |
| 58 | HIPK2 | 1.05401036 |
| 59 | FGFR3 | 1.03956962 |
| 60 | MAPK13 | 0.98064320 |
| 61 | PRKCH | 0.95213055 |
| 62 | PHKG2 | 0.93551786 |
| 63 | PHKG1 | 0.93551786 |
| 64 | FER | 0.91558185 |
| 65 | SIK2 | 0.91058048 |
| 66 | CAMK2A | 0.90304412 |
| 67 | BCR | 0.90246994 |
| 68 | MYLK | 0.89947025 |
| 69 | NEK6 | 0.88556887 |
| 70 | CDK14 | 0.87857405 |
| 71 | CAMK2B | 0.85760930 |
| 72 | LATS2 | 0.81063245 |
| 73 | SMG1 | 0.80325565 |
| 74 | MAP3K13 | 0.80304744 |
| 75 | CDK18 | 0.80024109 |
| 76 | CDK15 | 0.79436689 |
| 77 | ALK | 0.78219376 |
| 78 | TYRO3 | 0.77678831 |
| 79 | BMPR2 | 0.76251158 |
| 80 | ROCK2 | 0.75663499 |
| 81 | SGK494 | 0.75655871 |
| 82 | SGK223 | 0.75655871 |
| 83 | STK3 | 0.74795588 |
| 84 | SIK1 | 0.74754032 |
| 85 | CDK19 | 0.74493868 |
| 86 | BRSK1 | 0.73354264 |
| 87 | CSNK1G2 | 0.72787204 |
| 88 | TTK | 0.72189765 |
| 89 | CDC42BPA | 0.71739139 |
| 90 | PRKCI | 0.71596654 |
| 91 | WNK4 | 0.71567163 |
| 92 | FES | 0.69193128 |
| 93 | TAOK1 | 0.68347946 |
| 94 | CDK11A | 0.68053006 |
| 95 | BRAF | 0.68032880 |
| 96 | RAF1 | 0.67065331 |
| 97 | STK11 | 0.66847526 |
| 98 | PRPF4B | 0.66269636 |
| 99 | DYRK1A | 0.66214720 |
| 100 | CCNB1 | 0.65924985 |
| 101 | WNK1 | 0.65065428 |
| 102 | PDGFRA | 0.63474198 |
| 103 | MAP2K1 | 0.63171945 |
| 104 | CAMK1G | 0.62044469 |
| 105 | PRKCE | 0.61690770 |
| 106 | CAMK2D | 0.61365392 |
| 107 | EPHB2 | 0.60379131 |
| 108 | CAMK1 | 0.60211388 |
| 109 | ROCK1 | 0.60171759 |
| 110 | FRK | 0.59644053 |
| 111 | MAP3K3 | 0.59489132 |
| 112 | PTK2B | 0.59219863 |
| 113 | EPHB1 | 0.58943899 |
| 114 | TNIK | 0.58507245 |
| 115 | MARK2 | 0.58325916 |
| 116 | PTK2 | 0.57343598 |
| 117 | NEK1 | 0.57266597 |
| 118 | NME1 | 0.55396986 |
| 119 | AKT3 | 0.54338230 |
| 120 | SGK1 | 0.54155321 |
| 121 | SGK2 | 0.52906110 |
| 122 | FGFR4 | 0.52660032 |
| 123 | LMTK2 | 0.52235538 |
| 124 | PINK1 | 0.51731738 |
| 125 | ILK | 0.51470964 |
| 126 | PDPK1 | 0.51168599 |
| 127 | ERBB4 | 0.50446715 |
| 128 | BRSK2 | 0.50107106 |
| 129 | IRAK3 | 0.47502382 |
| 130 | PRKG2 | 0.47062823 |
| 131 | MAPK10 | 0.46988527 |
| 132 | PDK1 | 0.46426106 |
| 133 | RPS6KB2 | 0.45110008 |
| 134 | AKT2 | 0.44181519 |
| 135 | RPS6KA3 | 0.43504365 |
| 136 | CAMK2G | 0.42401445 |
| 137 | PTK6 | 0.42034485 |
| 138 | PRKAA2 | 0.41626327 |
| 139 | TSSK6 | 0.41616331 |
| 140 | MAP2K6 | 0.41430659 |
| 141 | RPS6KA2 | 0.40898077 |
| 142 | SGK3 | 0.40059819 |
| 143 | CSNK1G1 | 0.38236793 |
| 144 | PRKCZ | 0.38019109 |
| 145 | FGFR1 | 0.37451097 |
| 146 | DMPK | 0.36497648 |
| 147 | PRKAA1 | 0.34827960 |
| 148 | MAPKAPK5 | 0.34704926 |
| 149 | PRKD2 | 0.32583162 |
| 150 | RIPK1 | 0.32421536 |
| 151 | ADRBK1 | 0.31150239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.27779721 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.95138166 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 2.77719619 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.62043653 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.53631899 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.51395785 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.49396342 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.48592915 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.46721037 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.37663594 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.25789079 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.24737666 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.23593218 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.22557749 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.22089468 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 2.16966804 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03269379 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.02392910 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.99135444 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.88983884 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.88323737 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88173711 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.87830463 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.80401708 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.75678066 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.75143404 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.73577224 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.66252673 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.66023932 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65357442 |
| 31 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.63404938 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.57371619 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.56897312 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56459854 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.54907045 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.52215268 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49875810 |
| 38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41365669 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40211517 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.39118261 |
| 41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.38669756 |
| 42 | Tight junction_Homo sapiens_hsa04530 | 1.35694325 |
| 43 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.35612474 |
| 44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.33356174 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32664447 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.30395815 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.29695361 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28886934 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24253700 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17537167 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16302002 |
| 52 | Adherens junction_Homo sapiens_hsa04520 | 1.13932517 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.12974843 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10589309 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.09625778 |
| 56 | Glioma_Homo sapiens_hsa05214 | 1.04746885 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.04403334 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03677423 |
| 59 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.02379085 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01932451 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01848689 |
| 62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.01467142 |
| 63 | Melanogenesis_Homo sapiens_hsa04916 | 1.00376436 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98965451 |
| 65 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.95705842 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94970973 |
| 67 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.94626210 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93731026 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90778739 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89401806 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.88178550 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.88027797 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.86870067 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.84773985 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83837349 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82768810 |
| 77 | Focal adhesion_Homo sapiens_hsa04510 | 0.79310605 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.78758465 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77002870 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.74533816 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73905341 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73380759 |
| 83 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.73005354 |
| 84 | Axon guidance_Homo sapiens_hsa04360 | 0.72906666 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.71808625 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71723858 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69307185 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68353563 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68145984 |
| 90 | Alcoholism_Homo sapiens_hsa05034 | 0.68006202 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67830335 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66138532 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65761837 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.65600146 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.64470136 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63754694 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63753850 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63247735 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63220513 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62811068 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62680152 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60829531 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59092877 |
| 104 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.58118459 |
| 105 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57865534 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56808833 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56753921 |
| 108 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56558397 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56555389 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56441214 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55967065 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.55549908 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55494679 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54529696 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54288919 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53262110 |
| 117 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51639223 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51193178 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50484512 |
| 120 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50072722 |
| 121 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48580806 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47407972 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46680114 |
| 124 | Peroxisome_Homo sapiens_hsa04146 | 0.46298193 |
| 125 | Protein export_Homo sapiens_hsa03060 | 0.45503332 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45470769 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45445326 |
| 128 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45357260 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45049054 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.44747613 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44450393 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43489240 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.43328065 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43077368 |
| 135 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43063400 |
| 136 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42376792 |
| 137 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41951548 |
| 138 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.41792890 |
| 139 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40947326 |
| 140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39925699 |
| 141 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38460465 |
| 142 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37786563 |
| 143 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37252382 |
| 144 | Bile secretion_Homo sapiens_hsa04976 | 0.36460997 |
| 145 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36291517 |
| 146 | Lysosome_Homo sapiens_hsa04142 | 0.35336395 |
| 147 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34345687 |
| 148 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30984761 |
| 149 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30462434 |
| 150 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.28487916 |
| 151 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25874843 |
| 152 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.25049677 |

